Healthcare Sector — activité des initiés

Suivez les achats et ventes d’initiés sur les actions de Healthcare. Découvrez quels dirigeants achètent, l’activité nette des initiés et le pourcentage du flottant échangé parmi 3,435 sociétés.
Les informations fournies dans ce classement sont à titre informatif uniquement et ne constituent pas un conseil financier. Nous ne recommandons aucun investissement spécifique basé sur ces critères.
Entreprises
Données
Abonnez-vous pour accéder à l'ensemble des données
Entreprise Secteur d'activité Cap. boursière ($) # acheteurs nets Valeur nette achetée ($) % du flottant acheté % d'actions détenues par les initiés
Pharmaceuticals & Medical Research Mid (6.7bn) 1–5 $100M+ 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.6bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.4bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (6.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (6.3bn) 1–5 < $100K 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (6.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (6.1bn) 0 Aucune activité — 15–50%
US R1 RCM Inc (RCM)
Healthcare Services Mid (6.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (6.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.0bn) -1–5 -$100K–$1M -0–15% 50%+
Healthcare Services Mid (5.9bn) 0 < $100K 0–15% 0–15%
Healthcare Services Mid (5.9bn) 0 Aucune activité — 50%+
US Teleflex Inc (TFX)
Healthcare Services Mid (5.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (5.7bn) -1–5 -$1M–$10M -0–15% 0–15%
SE Sectra AB (SECT-B)
Healthcare Services Mid (5.6bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (5.6bn) -1–5 -$10M–$100M -0–15% 50%+
Pharmaceuticals & Medical Research Mid (5.6bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (5.5bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (5.5bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (5.5bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (5.4bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (5.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.4bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (5.4bn) 0 Aucune activité — 15–50%
CH Galenica AG (GALE)
Pharmaceuticals & Medical Research Mid (5.3bn) 0 Aucune activité — 0–15%
US LHC Group Inc (LHCG)
Healthcare Services Mid (5.3bn) 0 Aucune activité — 0–15%
US Grail Inc (GRAL)
Pharmaceuticals & Medical Research Mid (5.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.3bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (5.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.2bn) 0 Aucune activité — 15–50%
Healthcare Services Mid (5.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.2bn) 0 Aucune activité — 0–15%
US Erasca, Inc. (ERAS)
Pharmaceuticals & Medical Research Mid (5.1bn) 0 Aucune activité — 0–15%
US Heartflow Inc (HTFL)
Healthcare Services Mid (5.1bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (5.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (5.1bn) 1–5 $10M–$100M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.0bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (5.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.9bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.9bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.8bn) 0 Aucune activité — 0–15%
IN Ajanta Pharma Ltd (AJANTPHARM)
Pharmaceuticals & Medical Research Mid (4.8bn) 0 Aucune activité — 50%+
Healthcare Services Mid (4.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (4.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.6bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.6bn) 1–5 -$1M–$10M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (4.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (4.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 1–5 < $100K 0–15% 15–50%
Pharmaceuticals & Medical Research Mid (4.5bn) 1–5 $1M–$10M 0–15% 15–50%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (4.4bn) 0 Aucune activité — 50%+
US LivaNova PLC (LIVN)
Healthcare Services Mid (4.4bn) -1–5 -$100K–$1M -0–15% 0–15%
SE Medicover AB (MCOV-B)
Healthcare Services Mid (4.4bn) 0 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (4.3bn) -1–5 -$1M–$10M -0–15% 0–15%
GB Indivior Ltd (INDV)
Pharmaceuticals & Medical Research Mid (4.3bn) 1–5 < $100K 0–15% 0–15%
IN Biocon Ltd (BIOCON)
Pharmaceuticals & Medical Research Mid (4.3bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (4.3bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.3bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (4.2bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (4.2bn) -1–5 -$10M–$100M -0–15% 15–50%
US RadNet Inc (RDNT)
Healthcare Services Mid (4.2bn) 0 Aucune activité — 0–15%
US Alkermes Inc (ALKS)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 Aucune activité — 0–15%
US TESARO Inc (TSRO)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 Aucune activité — —
US Metsera Inc (MTSR)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.1bn) 1–5 < $100K 0–15% 50%+
Pharmaceuticals & Medical Research Mid (4.1bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (4.1bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Mid (4.1bn) 0 Aucune activité — 50%+
Healthcare Services Mid (4.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.8bn) 0 Aucune activité — 0–15%
SE Camurus AB (CAMX)
Pharmaceuticals & Medical Research Mid (3.8bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (3.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.8bn) 0 $1M–$10M 0–15% 15–50%
Healthcare Services Mid (3.8bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (3.8bn) 1–5 $100K–$1M 0–15% 50%+
US Perrigo Co (PRGO)
Pharmaceuticals & Medical Research Mid (3.8bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (3.7bn) -6–10 -$1M–$10M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (3.7bn) -1–5 -$1M–$10M -0–15% 0–15%
US CareDx, Inc. (CDNA)
Pharmaceuticals & Medical Research Mid (3.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 Aucune activité — 0–15%
US Organon & Co (OGN)
Pharmaceuticals & Medical Research Mid (3.6bn) 0 Aucune activité — 0–15%